Table of Contents

Volume 13 Issue 2
Volume 13 Issue 1
Volume 12 Issue 2
Volume 12 Issue 1

Please click here to browse prior individual issues.

EDITOR-IN-CHIEF

Dr. Faisal M. Arain, Vice President, Academic, Northern Lake College (NLC), Alberta, Canada. E-mail: faisal.arain@gmail.com

EDITORIAL ADVISORY BOARD

Dr. Hamimah Adnan, Universiti Teknologi MARA, Malaysia
Dr. David Chew Ah Seng, Nanyang Technological University, Singapore
Dr. Chimay J. Anumba, Pennsylvania State University, USA
Dr. Sadi Assaf, King Fahd University of Petroleum and Minerals, Saudi Arabia
Dr. Abdulaziz Bubshait, King Fahd University of Petroleum and Minerals, Saudi Arabia
Dr. Muhammad Dulaimi, British University in Dubai, United Arab Emirates
Dr. Charles Egbu, University of Salford, UK
Dr. Thoe C. Haupt, Cape Peninsula University of Technology, South Africa
Dr. Benedict Dozie Ilozor, Eastern Michigan University, USA
Dr. Imriyas Kamardeen, University of New South Wales, Australia
Dr. Abdul Samad Kazi, Technical Research Centre of Finland, Finland
Dr. Jun Ying Liu, Tianjin University, China
Dr. Low Sui Pheng, National University of Singapore, Singapore
Dr. Karen Manley, Queensland University of Technology, Australia
Dr. Paul Poh, Ryerson University, Canada
Dr. Larry Rosia, Saskatchewan Institute of Applied Science and Technology, Canada
Dr. Geoffrey Qiping Shen, Hong Kong Polytechnic University, Hong Kong
Dr. Brian Sloan, Napier University, UK
Dr. Syed Awais Ahmad Tipu, University of Sharjah, United Arab Emirates
Dr. Ron Wakefield, RMIT University, Australia

EDITORIAL REVIEW PANEL

Dr. Ajibade Ayodeji Aibinu, University of Melbourne, Australia
Dr. Tauha Hussain Ali, Mehran University of Engineering and Technology, Pakistan
Dr. Saad Al-Jibouri, University of Twente, The Netherlands
Dr. Ali M. Alyami, The General Admin. of Engnr in Saudi Border Guard, Saudi Arabia
Dr. Baabak Ashuri, Georgia Institute of Technology, USA
Dr. Salman Azhar, Auburn University, USA
Dr. Zeeshan Aziz, University of Illinois, USA
Dr. Tabarak Ballal, University of Reading, UK
Dr. Claudio Benghi, Faithful + Gould Inc., UK
Dr. Mohammed A. Berawi, University of Indonesia, Indonesia
Dr. David G. Carmichael, University of New South Wales, Australia
Dr. Albert P.C. Chan, Hong Kong Polytechnic University, Hong Kong
Dr. Paul W. Chan, University of Manchester, UK
Dr. Sai On Cheung, City University of Hong Kong, Hong Kong
Dr. Nicholas Chileshe, University of South Australia, Australia
Dr. Rafiq Muhammad Choudhry, National University of Sciences and Tech., Pakistan
Dr. Hemanta K. Doloi, University of Melbourne, Australia
Dr. David Edwards, Loughborough University, UK
Dr. Adnan Enshassi, Islamic University Gaza, Palestinian Authority
Dr. Abdolhamid (Hamid) Ghanbari, Homeowner Protection Office, Canada
Dr. Jane Hao, Ryerson University, Canada
Dr. Mohammad A. Hassanain, King Fahd Univ. of Petroleum & Minerals, Saudi Arabia
Dr. Paul Ho, City University of Hong Kong, Hong Kong
Dr. Ahmed Doko Ibrahim, Ahmadu Bello University, Nigeria
Dr. Malik M.A. Khalfan, University of Salford, UK
Dr. Young Hoon Kwak, George Washington University, USA
Dr. Ellen Lau, City University of Hong Kong, Hong Kong
Dr. Kerry London, University of Newcastle, Australia
Dr. Mohamed Mahdy Marzouk, Cairo University, Egypt
Dr. Ibrahim A. Motawa, Heriot-Watt University, UK
Dr. Min Wu, University of Hong Kong, Hong Kong
Dr. Ronie Navon, Isreal Institute of Technology, Israel
Dr. Udechukwu ‘Udi’ Ojiako, Northumbria University, UK
Dr. Michael Okoroh, University of Derby, UK
Dr. Bob Owen, University of Salford, UK
Dr. John-Paris Pantouvakis, National Technical University of Athens, Greece
Dr. Srinath Perera, University of Ulster, UK
Dr. Alexander Pichura, Korea Advanced Inst. of Science & Technology, S. Korea
Dr. Joanna Poon, Nottingham Trent University, UK
Dr. Zulkiflee Abdul Samad, University of Malaya, Malaysia
Dr. Stephen Simister, University of Reading, UK
Dr. James Sommerville, Glasgow Caledonian University, UK
Dr. Paul Stephenson, Sheffield Hallam University, UK
Dr. Fan Su-Ling, (Laura) TamKang University, Taiwan
Dr. Akhmad Suraji, The First Secretary for National Construction Services Development, Indonesia
Dr. Vivian W.Y. Tam, University of Western Sydney, Australia
Dr. Willie Tan, National University of Singapore, Singapore
Dr. Soren Wandahl, Aalborg University, Denmark
Dr. Clive Warren, University of Queensland, Australia
Dr. Jian Zuo, University of South Australia, Australia

NOTES FOR CONTRIBUTORS

International Journal of Construction Project Management is a peer-reviewed journal that publishes two issues per year. The journal is owned and operated by Nova Science Publishers and funded entirely by subscription revenue and author-optional publication services.

There is no charge to submit your article and have it published in the journal. Nova offers a number of optional publication services that carry fees, but authors are not required to select these services, and the services won’t be offered until after acceptance of the articles. These services include Open Access, color printing, article offprints, discounted print copies of the journal issue, and licenses for use of the published articles.

Submission of an article must be accompanied by a signed Copyright Transfer and Disclosure Form, which can be printed or downloaded here: https://novapublishers.com/wp-content/uploads/2021/09/CTDF-Copyright-Transfer-and-Disclosure-Form.pdf. Submissions that do not include a signed Copyright Transfer and Disclosure Form will be treated as incomplete.

Authors will receive a complimentary PDF of his or her final article(s) upon publication.

Authors may deposit and display the proofed versions of their articles in and on their personal non-commercial and affiliate non-commercial repositories and websites at any time. The same may be done with their final published articles only after a period of one year has elapsed from the day of publication.

Manuscript Submissions
Before submitting your article, please read the complete notes and instructions below to ensure that you understand Nova’s manuscript requirements and publication procedures and that you are in compliance with the ethical standards rightfully set forth by Nova, the publishing industry, and the scientific community.

Articles should be submitted by in MS Word format by email to the Editor-in-Chief, Dr. Faisal M. Arain.

Dr. Faisal M. Arain
Vice President, Academic
Northern Lake College (NLC)
Alberta, Canada
E-mail: faisal.arain@gmail.com

It is understood that articles submitted to the journal have not been submitted elsewhere for simultaneous publication consideration and have not been previously published, in whole or in part, unless the new article is an expansion of the original, in which case full transparency of the re-used portions must be provided. Please note that articles cannot be retracted or withdrawn after they have been published.

Manuscript Preparation
Submissions must include the following items in the order listed:

• A Title Page that includes the title of the manuscript and each author’s name, affiliation, mailing address, phone number, fax number, and e-mail address. Correspondence will be directed only to the first author listed.
• An Abstract of 100 words or less that outlines the purpose, scope, and conclusions of the manuscript. The Abstract should be followed by at least three Keywords.
• Article text with headings but no more than two levels of subheadings. In order to permit objective reviews by two referees, the Abstract and all the pages of the text should be void of any identifying information such as authors’ names and affiliations.
• References.
• Illustrations and Tables. These should be titled, numbered in Arabic numerals with captions, and each on a separate sheet. The preferred location of each illustration should be indicated within the body of the text.
• Biographical details of each author along with a photo.

Manuscript Specifications
• Manuscripts must be written in English.
• Times New Roman 12-pt. font, double spaced, single column.
• Margins should be 1 inch.
• Manuscripts should not exceed 7,000 words.
• Manuscripts must begin with an Abstract of 100 words or less, written in English, that outlines the purpose, scope, and conclusions.
• Manuscripts should include at least three keywords after the Abstract.
• For any explanatory notes, please use footnotes.

Illustrations
All diagrams, photographs, illustrations, and charts (not tables) should be referred to in the text as Figures, and they should be numbered consecutively with Arabic numerals. These figures must be supplied as separate electronic files named in the format in which they were created, and they must be one of the following types: tiff, bitmap, jpeg, gif, ppt, psd, png, or eps. The resolution of these figures must be at least 300 dpi and of good contrast. Please use patterning instead of colors for all graphs and charts when possible. Each Figure should include a title and short description.

Figures must also be placed inside or at the end of the manuscript. If scanned images are used, please retain the original hard copy of the figure for possible transmission to Nova Science Publishers. If previously published figures are used, written permission from the copyright holders must be obtained and submitted along with the text indicating the copyright holder’s citation instructions. Such permissions must grant unrestricted use.

References
Examples of acceptable forms of reference lists at the end of the chapter are given below:

Articles in Journals
• Author, A. A. (Year of Publication). Title of journal article. Title of journal, volume number, first page-last page.
• Author, A. A., & Author, B. B. (1996). Title of journal article: Subtitle of journal article. Title of journal, volume
number, first page-last page.
• Author, A. A., Author, B. B., & Author, C. C. (1996). Title of journal article. Title of journal: Subtitle of journal, volume number (issue number), first page-last page.

Books
• Author, A. A. (1996). Title of book. City: Publisher.
• Author, A. A., & Author, B. B. (1996). Title of book: Subtitle of book (edition). City, ST: Publisher.
• Author, A. A., Author, B. B., & Author, C. C. (1996). Title of book: Vol. 1. Title of series. City, Country: Publisher.

Articles in Edited Books
• Author, A. A. (1996). Title of chapter. In E. E. Editor (Ed.), Title of book (pp. first page-last page). City: Publisher.
• Author, A. A., & Author, B. B. (1996). Title of chapter: Subtitle of chapter. In E. E. Editor, & F. F. Editor (Eds.),
Title of book: Subtitle of book (edition, pp. first page-last page). City, ST: Publisher.
• Author, A. A., Author, B. B., & Author, C. C. (1996). Title of chapter: Subtitle of chapter. In E. E. Editor, F. F.
Editor, & G. G. Editor (Eds.), Title of book: Subtitle of book (edition, pp. first page-last page). City, Country: Publisher.

Electronic Media
• Author, A. A. (1996). Title of electronic text [E-text type]. Location of document
• Author, A. A., & Author, B. B. (1996). Title of electronic journal article. Title of electronic journal [On-line serial], Volume number (Issue number).

Peer-Review
Double-blind peer-review and publication decision are carried out and made by the Editor-in-Chief in cooperation with the Editorial Board.

Publication Ethics
Nova is committed to maintaining trust in the journal, the value of authorship, and the integrity of science. Authors should be eager to help us maintain these standards. The following guidelines are provided to help authors avoid the appearance of ethical misconduct in their research and to help ensure adherence to the best practices set forth by national and international professional and regulatory bodies.

Plagiarism is a blight on the scientific community and a crime. The unauthorized use or close imitation of another’s language, text, data, ideas, or theories is prohibited. In all instances of authorized use, full credit to and representation of the original author’s work must be provided. It is the authors’ responsibility to secure permission for the use of copyrighted material.

The journal will investigate all reports and suspicions of plagiarism. Authors suspected of plagiaristic misconduct will be contacted and given the opportunity to prove the validity of their work and refute the allegations. All instances of proven plagiarism will be reported to the Publisher, the editorial office, the author’s institute, and other governing bodies as necessary. Plagiarized articles already accepted for publication will be cancelled, and plagiarized articles that have already been published will be retracted and denounced in a public erratum.

It is important that all authors and organizations where the research has been carried out have consented to the work’s submission and that all authors have significantly contributed.

In order to establish transparency in research, authors should be sure to provide information on the following items.

1) Information regarding the source(s) of the work’s funding;
2) All financial and non-financial potential conflicts of interest;
3) A statement of informed consent for all studies that involve human participants;
4) A statement of human rights for all studies that involve human participants;
5) A statement on the humane treatment and proper welfare of all animals involved in the study.

The appropriate statements are provided below. They should be included in the article’s text in a section titled Ethical Compliance. This section should immediately precede the References section

1) Sources of Funding
Please provide the names of all funding agencies, research grants, and grant numbers.

Statement
Source of Funding: This study was funded by ____________________.

2) Potential Conflicts of Interest
Authors are required to disclose all personal and professional relationships and interests that can be viewed as potentially imparting bias in the work. Readers are entitled to this information and to their own conclusions and perceptions of conflict. Potential conflicts could be financial relationships, employment, sponsorships, public holdings, competing interests, spousal interests, personal relationships, personal beliefs, etc.

Statement
a) Disclosure of Interest: The authors declare that they have no conflict of interest.

or

b) Disclosure of Interest:

3) Informed Consent
Study participants have the right to decide how the identifiable personal information gathered on them is used. It is essential that all participants (or guardians) give their written informed consent to participate in the study and its subsequent publication.

Statement
Informed consent was obtained from each individual participant involved in this study.

4) Statement of Human Rights
The wellbeing of human subjects takes precedence over the interests of science. If a study involves human participants, authors should include a statement that the study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.

Statement
This study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.

5) Statement of Animal Welfare
All studies that involve animals should contain a statement that the study and its procedures have been approved by their affiliate institutional research ethics committee.

Statement
All animals involved in this study were treated in accordance with the ethical standards set forth by the institution at which the study was conducted.

Committee on Publication Ethics
Nova and its editors follow the Codes of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE). These codes and guidelines are valuable instructions that ensure transparency and fairness in research and publishing. The single document provides steps for submissions, peer-review, confidentiality, the creation and maintenance of editorial boards, editorial responsibilities and decision-making, communication policy, appeal procedures, handling complaints and instances of misconduct, quality assurance, publishing corrections and retractions, adherence to national and international ethics guidelines, and many more aspects of the publication process.

The COPE Codes of Conduct and Best Practice Guidelines can be read at the link below. We recommend your familiarity with them while you publish with Nova and any other scientific publisher.
https://publicationethics.org/resources/code-conduct

If you notice any ethical misconduct in Nova’s publications, please contact us.

Publisher’s Office
Nova Science Publishers, Inc.
415 Oser Avenue, Suite N
Hauppauge, New York 11788, USA
Phone: (631) 231-7269
E-mail: nova.main@novapublishers.com

Advertising Opportunities
Please contact our office using the information above.